Polymerization of human angiotensinogen: Insights into its structural mechanism and functional significance

Biochemical Journal

Volumn 400, Issue 1, 2006, Pages 169-178

  Stanley, Peter ^a   Serpell, Louise C ^b   Stein, Penelope E ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

Angiotensinogen; Hypertension; Non inhibitory; Polymers; Renin; Serpin

Indexed keywords

BLOOD; ELECTRON MICROSCOPY; MOLECULAR STRUCTURE; MOLECULAR WEIGHT; PLASMAS; POLYMERIZATION;

ANGIOTENSINOGEN; HYPERTENSION; RENIN; SERPIN;

PROTEINS;

ANGIOTENSIN I; ANGIOTENSINOGEN; HISTIDINE; RENIN; SERINE PROTEINASE INHIBITOR;

AMINO TERMINAL SEQUENCE; ARTICLE; BLOOD PRESSURE; CHEMICAL MODIFICATION; CIRCULAR DICHROISM; ELECTRON MICROSCOPY; HUMAN; HYPERTENSION; IN VITRO STUDY; MOLECULAR WEIGHT; POLYMERIZATION; PRIORITY JOURNAL;

ANGIOTENSINOGEN; CIRCULAR DICHROISM; DIMERIZATION; DISULFIDES; HUMANS; HYDROGEN-ION CONCENTRATION; MICROSCOPY, ELECTRON; MODELS, MOLECULAR; PHOSPHATES; PROTEIN CONFORMATION; PROTEIN FOLDING; RENIN; SODIUM CHLORIDE; TEMPERATURE; UREA;

EID: 33751087751     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20060444     Document Type: Article

References (49)

1. Doolittle, R. F. (1983) Angiotensinogen is related to the antitrypsin-antithrombin-ovalbumin family. Science 222, 417-419
2. Irving, J. A., Pike, R. N., Lesk, A. M. and Whisstock, J. C. (2000) Phylogeny of the serpin superfamily: implications of patterns of amino acid conservation for structure and function. Genome Res. 10, 1845-1864
3. Stein, P. E., Tewksbury, D. A. and Carrell, R. W. (1989) Ovalbumin and angiotensinogen lack serpin S → R conformational change. Biochem. J. 262, 103-107
4. Becerra, S. P., Sagasti, A., Spinella, P. and Notario, V. (1995) Pigment epithelium-derived factor behaves like a noninhibitory serpin. Neurotrophic activity does not require the serpin reactive loop. J. Biol. Chem. 270, 25992-25999
5. Pemberton, P. A., Wong, D. T., Gibson, H. L., Kiefer, M. C., Fitzpatrick, P. A., Sager, R. and Barr, P. J. (1995) The tumor suppressor maspin does not undergo the stressed to relaxed transition or inhibit trypsin-like serine proteases. Evidence that maspin is not a protease inhibitory serpin. J. Biol Chem. 270, 15832-15837
6. Gould, A. B. and Green, D. (1971) Kinetics of the human renin and human substrate reaction. Cardiovasc. Res. 5, 86-89
7. Skeggs, L. T., Dorer, F. E., Kahn, J. R., Lentz, K. E. and Levine, M. (1976) The biochemistry of the renin-angiotensin system and its role in hypertension. Am. J. Med. 60, 737-748
8. Lalouel, J. M., Rohrwasser, A., Terreros, D., Morgan, T. and Ward, K. (2001) Angiotensinogen in essential hypertension: from genetics to nephrology. J. Am. Soc. Nephrol. 12, 606-615
9. Tewksbury, D. A., Frome, W. L. and Dumas, M. L. (1978) Characterization of human angiotensinogen. J. Biol. Chem. 253, 3817-3820
10. Campbell, C. J., Charlton, P. A., Grinham, C. J., Mooney, C. J. and Pendlebury, J. E. (1987) The rapid purification and partial characterization of human serum angiotensinogen. Biochem. J. 243, 121-126
11. Gordon, D. B. and Sachin, I. N. (1977) Chromatographic separation of multiple renin substrates in women: effect of pregnancy and oral contraceptives. Proc. Soc. Exp. Biol. Med. 156, 461-464
12. Tewksbury, D. A. and Dart, R. A. (1982) High molecular weight angiotensinogen levels in hypertensive pregnant women. Hypertension 4, 729-734
13. Tetlow, H. J. and Broughton-Pipkin, F. (1986) Changing renin substrates in human pregnancy. J. Endocrinol. 109, 257-262
14. Lenz, T., Sealey, J. E. and Tewksbury, D. A. (1993) Regional distribution of the angiotensinogens in human placentae. Placenta 14, 695-699
15. Christiansen, M., Jaliashvili, I., Overgaard, M. T., Ensinger, C., Obrist, P. and Oxvig, C. (2000) Quantification and characterization of pregnancy-associated complexes of angiotensinogen and the proform of eosinophil major basic protein in serum and amniotic fluid. Clin. Chem. 46, 1099-1105
16. Tewksbury, D. A. and Tryon, E. S. (1989) Immunochemical comparison of high molecular weight angiotensinogen from amniotic fluid, plasma of men, and plasma of pregnant women. Am. J. Hypertens. 2, 411-413
17. Tewksbury, D. A. (1996) Quantitation of five forms of high molecular weight angiotensinogen from human placenta. Am. J. Hypertens. 9, 1029-1034
18. Ramaha, A., Celerier, J. and Patston, P. A. (2003) Characterization of different high molecular weight angiotensinogen forms. Am. J. Hypertens. 16, 478-483
19. Tewksbury, D., Frome, W., Kaiser, S. and Vevea, D. (1997) 38, Study of the composition and formation of high molecular weight angiotensinogen. Abstracts of the 12th Scientific Meeting of the Inter-American Society of Hypertension, Mexico City, Mexico
20. Tewksbury, D. A., Goodman, J. R., Kaiser, S. J., Burrill, R. E. and Brown, H. L. (2000) Quantitation of the five forms of plasma high molecular weight angiotensinogen in women with pregnancy-induced hypertension. Am. J. Hypertens. 13, 221-225
21. Celerier, J., Schmid, G., Le Caer, J. P., Gimenez-Roqueplo, A. P., Bur, D., Friedlein, A., Langen, H., Corvol, P. and Jeunemaitre, X. (2000) Characterization of a human angiotensinogen cleaved in its reactive center loop by a proteolytic activity from Chinese hamster ovary cells. J. Biol. Chem. 275, 10648-10654
22. Shionoiri, H., Gotoh, E., Kaneko, Y., Eggena, P. and Sambhi, M. P. (1983) Differences in the kinetic rate constants of normal and high molecular weight renin substrate from term pregnancy human plasma. Endocrinol. Jpn. 30, 731-736
23. Tryon, E. S. and Tewksbury, D. A. (1995) Kinetic analysis of the reaction of human renin with human high and low molecular weight angiotensinogen. Hypertens. Preg. 14, 327-338
24. Tewksbury, D. A., Premeau, M. R., Dumas, M. L. and Frome, W. L. (1977) Purification of human angiotensinogen. Circ. Res. 41, 29-33
25. Schagger, H. and von Jagow, G. (1987) Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166, 368-379
26. Towbin, H., Staehelin, T. and Gordon, J. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U.S.A. 76, 4350-4354
27. Dafforn, T. R., Mahadeva, R., Elliott, P. R., Sivasothy, P. and Lomas, D. A. (1999) A kinetic mechanism for the polymerization of α1-antitrypsin. J. Biol. Chem. 274, 9548-9555
28. Bruch, M., Weiss, V. and Engel, J. (1988) Plasma serine proteinase inhibitors (serpins) exhibit major conformational changes and a large increase in conformational stability upon cleavage at their reactive sites. J. Biol. Chem. 263, 16626-16630
29. Streatfeild-James, R. M., Williamson, D., Pike, R. N., Tewksbury, D., Carrell, R. W. and Coughlin, P. B. (1998) Angiotensinogen cleavage by renin: importance of a structurally constrained N-terminus. FEBS Lett. 436, 267-270
30. Lomas, D. A., Finch, J. T., Seyama, K., Nukiwa, T. and Carrell, R. W. (1993) α1-antitrypsin Siiyama (Ser53→Phe). Further evidence for intracellular loop-sheet polymerization. J. Biol. Chem. 268, 15333-15335
31. Davis, R. L., Shrimpton, A. E., Holohan, P. D., Bradshaw, C., Feiglin, D., Collins, G. H., Sonderegger, P., Kinter, J., Becker, L. M., Lacbawan, F. et al. (1999) Familial dementia caused by polymerization of mutant neuroserpin. Nature 401, 376-379
32. Lomas, D. A., Evans, D. L., Finch, J. T. and Carrell, R. W. (1992) The mechanism of Z α1-antitrypsin accumulation in the liver. Nature 357, 605-607
33. Mahadeva, R., Chang, W. S., Dafforn, T. R., Oakley, D. J., Foreman, R. C., Calvin, J., Wight, D. G., Stein, P. E. and Carrell, R. W. (1995) Heteropolymerization of S, I, and Z α1-antitrypsin and liver cirrhosis. Nat. Struct. Biol. 2, 96-113
34. Crowther, D. C., Serpell, L. C., Dafforn, T. R., Gooptu, B. and Lomas, D. A. (2003) Nucleation of α1-antichymotrypsin polymerization. Biochemistry 42, 2355-2363
35. Zhou, A., Faint, R., Charlton, P., Dafforn, T. R., Carrell, R. W. and Lomas, D. A. (2001) Polymerization of plasminogen activator inhibitor-1. J. Biol. Chem. 276, 9115-9122
36. Sivasothy, P., Dafforn, T. R., Gettins, P. G. and Lomas, D. A. (2000) Pathogenic α1-antitrypsin polymers are formed by reactive loop-β-sheet A linkage. J. Biol. Chem. 275, 33663-33668
37. Stein, P. and Chothia, C. (1991) Serpin tertiary structure transformation. J. Mol. Biol. 221, 615-621
38. Lomas, D. A., Elliott, P. R., Chang, W. S., Wardell, M. R. and Carrell, R. W. (1995) Preparation and characterization of latent α1-antitrypsin. J. Biol. Chem. 270, 5282-5288
39. Elliott, P. R., Lomas, D. A., Carrell, R. W. and Abrahams, J. P. (1996) Inhibitory conformation of the reactive loop of α1-antitrypsin. Nat. Struct. Biol. 3, 676-681
40. Bruce, D., Perry, D. J., Borg, J. Y., Carrell, R. W. and Wardell, M. R. (1994) Thromboembolic disease due to thermolabile conformational changes of antithrombin Rouen-VI (187 Asn→Asp) J. Clin. Invest. 94, 2265-2274
41. Carrell, R. W., Stein, P. E., Fermi, G. and Wardell, M. R. (1994) Biological implications of a 3A structure of dimeric antithrombin. Structure 2, 257-270
42. Lomas, D. A., Elliott, P. R., Sidhar, S. K., Foreman, R. C., Finch, J. T., Cox, D. W., Whisstock, J. C. and Carrell, R. W. (1995) α1-Antitrypsin Mmalton (Phe52Δ) forms loop-sheet polymers in vivo. Evidence for the C sheet mechanism of polymerization. J. Biol. Chem. 270, 16864-16870
43. Sharp, A. M., Stein, P. E., Pannu, N. S., Carrell, R. W., Berkenpas, M. B., Ginsburg, D., Lawrence, D. A. and Read, R. J. (1999) The active conformation of plasminogen activator inhibitor 1, a target for drugs to control fibrinolysis and cell adhesion. Structure 7, 111-118
44. Schulze, A. J., Baumann, U., Knof, S., Jaeger, E., Huber, R. and Laurell, C. B. (1990) Structural transition of α1-antitrypsin by a peptide sequentially similar to β-strand s4A. Eur. J. Biochem. 194, 51-56
45. Ramaha, A. and Patston, P. A. (2002) Release and degradation of angiotensin I and angiotensin II from angiotensinogen by neutrophil serine proteinases. Arch. Biochem. Biophys. 397, 77-83
46. Tewksbury, D. A., Pan, N. and Kaiser, S. J. (2003) Detection of a receptor for angiotensinogen on placental cells. Am. J. Hypertens. 16, 59-62
47. Carrell, R. W. and Stein, P. E. (1996) The biostructural pathology of the serpins: critical function of sheet opening mechanism. Biol. Chem. Hoppe-Seyler 377, 1-17
48. Lomas, D. A. and Carrell, R. W. (2002) Serpinopathies and the conformational dementias. Nat. Rev. Genet. 3, 759-768
49. Stein, P. E. and Carrell, R. W. (1995) What do dysfunctional serpins tell us about molecular mobility and disease? Nat. Struct. Biol. 2, 96-113